Gist of South Korean Panel's Findings on Stem Cell Research
Posted on: Tuesday, 10 January 2006, 00:02 CST
Text of report in English by South Korean news agency Yonhap
Seoul, 10 January: The following is the gist of a final report issued Tuesday [10 January] by a Seoul National University panel to determine the authenticity of cloning expert Hwang Woo-suk's past stem cell research.
The panel concluded:
- Hwang used false data in his 2004 Science paper, and no genuine embryonic stem cell existed to support the research.
- The embattled stem cell scientist did not possess the technology required to create embryonic stem cells.
- Afghan Hound Snuppy is indeed the world's first cloned dog as claimed by Hwang.
- Conclusive DNA analysis of alleged stem cell lines provided by Hwang's team revealed that none could be considered as genuine, stem cells. Three local labs had been contacted to conduct the DNA testing starting on 22 December.
- Hwang and his team used more human ova in their research than they acknowledged to Science magazine, with a total of 2,000 human eggs having been provided to the stem cell cloning team. Hwang had claimed he went through 242 eggs to successfully make a single stem cell in the 2004 paper, and 185 eggs to make 11 individually tailored stem cells in the May 2005 report.
- The seriousness of the data fabrication required disciplinary action to be taken against all people involved in Hwang's research. The university's internal disciplinary committee is expected to be convened.
- The panel could not confirm whether Hwang's embryonic stem cells were switched with fertilized stem cells created by MizMedi Hospital and referred the case to the public prosecution.
- Measures will be taken, based on information collected in the past month, to prevent future fabrications. The investigation results will be forwarded to the foreign scientific community and science journals.
Source: BBC Monitoring Newsfile
Related Articles
- Governor's Signing of Green Chemistry Legislation Applauded By Science Advisory Panel Member
- Cytori Selected By Fraunhofer Society to Develop New Stem and Regenerative Cell-Based Treatments for Stroke
- First Three Patients Treated in Adipose Stem and Regenerative Cell Clinical Safety and Feasibility Study for Breast Reconstruction; Represents First Clinical Use of Cytori's Regenerative Cell Processing System
- Geron Announces Issuance of U.S. Patent for Production of Insulin Secreting Cells From Human Embryonic Stem Cells
- Cytori Therapeutics Reports Benefit of Adipose Stem and Regenerative Cells in Reconstructive Surgery From Preclinical Study
- Clinical Safety and Feasibility Study Initiated Using Adipose Stem and Regenerative Cells in Breast Reconstruction Procedures
- Geron Enters Into Research and Exclusive License Agreements With the University of Oxford for Derivation of Dendritic Cells From Human Embryonic Stem Cells
- RPCC Instructor Sits on Science Foundation Panel
- New York Blood Center Praises Passage of Stem Cell Therapeutic & Research Act of 2005 Which Will Help Save Lives of Thousands
- Greer Adds Prominent Research Immunologist to Research and Development Team
 |
 |
User Comments (0)
RSS Feeds